CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Alteogen Inc Company Snapshot
Alteogen Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alteogen Inc with three other companies in this sector in South Korea: Eu Biologics Co Ltd (2017 sales of 11.57 billion Korean Won [US$10.12 million] ), Corestem Inc (18.09 billion Korean Won [US$15.83 million] of which 85% was The clinical trial agent), and Tego Science Inc (8.64 billion Korean Won [US$7.56 million] ).

Sales Analysis. Alteogen Inc reported sales of 12.10 billion Korean Won (US$10.59 million) for the year ending December of 2017. This represents an increase of 76.9% versus 2016, when the company's sales were 6.84 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Alteogen Inc
  Stock Performance Chart for Alteogen Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 31,600
(Figures in Korean Won)
1 Week -5.8%   13 Weeks -6.8%  
4 Weeks 6.8%   52 Weeks 112.1%  
 
Alteogen Inc Key Data:
  Ticker: 196170 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 12,104,355,843
(Year Ending Jan 2018).
Employees: 39
  Currency: Korean Won Market Cap: 399,526,068,000
  Fiscal Yr Ends: December Shares Outstanding: 12,643,230
  Share Type: Common Closely Held Shares: 4,272,846
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.